Terms: = Prostate cancer AND NDRG1, NDR1, 10397, ENSG00000104419, Q92597, RIT42, CMT4D, TARG1, HMSNL, GC4, RTP, TDD5, PROXY1, NMSL, CAP43
99 results:
1. Long noncoding RNA MEG3 regulates cell proliferation and apoptosis by disrupting microRNA-9-5p-mediated inhibition of ndrg1 in prostate cancer.
Lian Z; Tian P; Ma S; Chang T; Liu R; Feng Q; Li J
Aging (Albany NY); 2024 Jan; 16(2):1938-1951. PubMed ID: 38271137
[TBL] [Abstract] [Full Text] [Related]
2. A review of nuclear Dbf2-related kinase 1 (ndr1) protein interaction as promising new target for cancer therapy.
Lu J; Feng Y; Yu D; Li H; Li W; Chen H; Chen L
Int J Biol Macromol; 2024 Feb; 259(Pt 1):129188. PubMed ID: 38184050
[TBL] [Abstract] [Full Text] [Related]
3. Androgen Receptor Upregulates Mucosa-Associated Lymphoid Tissue 1 to Induce NF-κB Activity via Androgen-Dependent and -Independent Pathways in prostate Carcinoma Cells.
Chang KS; Chen ST; Sung HC; Hsu SY; Lin WY; Hou CP; Lin YH; Feng TH; Tsui KH; Juang HH
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047218
[TBL] [Abstract] [Full Text] [Related]
4. WNT1 Inducible Signaling Pathway Protein 1 Is a Stroma-Specific Secreting Protein Inducing a Fibroblast Contraction and Carcinoma Cell Growth in the Human prostate.
Chang KS; Chen ST; Sung HC; Hsu SY; Lin WY; Hou CP; Lin YH; Feng TH; Tsui KH; Juang HH
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232736
[TBL] [Abstract] [Full Text] [Related]
5. Monte Carlo modeling of the Elekta Versa HD and patient dose calculation with EGSnrc/BEAMnrc.
Paschal HMP; Kabat CN; Papaconstadopoulos P; Kirby NA; Myers PA; Wagner TD; Stathakis S
J Appl Clin Med Phys; 2022 Sep; 23(9):e13715. PubMed ID: 35985698
[TBL] [Abstract] [Full Text] [Related]
6. MiR-96-5p induced ndrg1 deficiency promotes prostate cancer migration and invasion through regulating the NF-κB signaling pathway.
Lian Z; Chang T; Ma S; Li J; Zhang H; Wang X; Liu R
Cancer Biomark; 2022; 35(1):83-98. PubMed ID: 35912726
[TBL] [Abstract] [Full Text] [Related]
7. Expression and clinicopathological significance of glucocorticoid receptor, SGK1, and ndrg1 in hormone-naïve prostate carcinoma.
Hata S; Shimada H; Sato N; Koshiishi M; Ise K; Ogata T; Yamashita S; Ito A; Sasano H; Nakamura Y
Med Mol Morphol; 2022 Dec; 55(4):283-291. PubMed ID: 35861941
[TBL] [Abstract] [Full Text] [Related]
8. Proteome profiling of enzalutamide-resistant cell lines and serum analysis identified ALCAM as marker of resistance in castration-resistant prostate cancer.
Csizmarik A; Keresztes D; Nagy N; Bracht T; Sitek B; Witzke K; Puhr M; Tornyi I; Lázár J; Takács L; Kramer G; Sevcenco S; Maj-Hes A; Jurányi Z; Hadaschik B; Nyirády P; Szarvas T
Int J Cancer; 2022 Oct; 151(8):1405-1419. PubMed ID: 35689436
[TBL] [Abstract] [Full Text] [Related]
9. 3D-T2W-TSE radiotherapy treatment planning MRI using compressed sensing acceleration for prostate cancer: Image quality and delineation value.
Wong OL; Poon DMC; Kam MKM; Lo GG; Fung WWK; Man SY; Xue C; Yu SK; Cheung KY; Yuan J
Asia Pac J Clin Oncol; 2022 Oct; 18(5):e369-e377. PubMed ID: 35073460
[TBL] [Abstract] [Full Text] [Related]
10. The metastasis suppressor ndrg1 directly regulates androgen receptor signaling in prostate cancer.
Lim SC; Geleta B; Maleki S; Richardson DR; Kovačević Ž
J Biol Chem; 2021 Dec; 297(6):101414. PubMed ID: 34785213
[TBL] [Abstract] [Full Text] [Related]
11. SPOP mutation induces DNA methylation via stabilizing GLP/G9a.
Zhang J; Gao K; Xie H; Wang D; Zhang P; Wei T; Yan Y; Pan Y; Ye W; Chen H; Shi Q; Li Y; Zhao SM; Hou X; Weroha SJ; Wang Y; Zhang J; Karnes RJ; He HH; Wang L; Wang C; Huang H
Nat Commun; 2021 Sep; 12(1):5716. PubMed ID: 34588438
[TBL] [Abstract] [Full Text] [Related]
12. The role of N-cadherin/c-Jun/ndrg1 axis in the progression of prostate cancer.
Quan Y; Zhang X; Butler W; Du Z; Wang M; Liu Y; Ping H
Int J Biol Sci; 2021; 17(13):3288-3304. PubMed ID: 34512147
[TBL] [Abstract] [Full Text] [Related]
13. FOXP1 and ndrg1 act differentially as downstream effectors of RAD9-mediated prostate cancer cell functions.
Panigrahi SK; Broustas CG; Cuiper PQ; Virk RK; Lieberman HB
Cell Signal; 2021 Oct; 86():110091. PubMed ID: 34298089
[TBL] [Abstract] [Full Text] [Related]
14. The expression of YWHAZ and ndrg1 predicts aggressive outcome in human prostate cancer.
Lage-Vickers S; Bizzotto J; Valacco MP; Sanchis P; Nemirovsky S; Labanca E; Scorticati C; Mazza O; Mitrofanova A; Navone N; Vazquez E; Cotignola J; Gueron G
Commun Biol; 2021 Jan; 4(1):103. PubMed ID: 33483585
[TBL] [Abstract] [Full Text] [Related]
15. Identification of PIM1 substrates reveals a role for ndrg1 phosphorylation in prostate cancer cellular migration and invasion.
Ledet RJ; Ruff SE; Wang Y; Nayak S; Schneider JA; Ueberheide B; Logan SK; Garabedian MJ
Commun Biol; 2021 Jan; 4(1):36. PubMed ID: 33398037
[TBL] [Abstract] [Full Text] [Related]
16. An unusual case of oedematous prostate volumetric changes observed over the course of radiotherapy on the MR linear accelerator.
Clough A; Bridge P; Hales R; McDaid L; Choudhury A; Eccles CL
J Med Imaging Radiat Sci; 2021 Mar; 52(1):147-151. PubMed ID: 33342695
[TBL] [Abstract] [Full Text] [Related]
17. The Role of Extracellular Proteases in Tumor Progression and the Development of Innovative Metal Ion Chelators that Inhibit their Activity.
Park KC; Dharmasivam M; Richardson DR
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32948029
[TBL] [Abstract] [Full Text] [Related]
18. Identification of Potential Key Genes and Pathways in Enzalutamide-Resistant prostate cancer Cell Lines: A Bioinformatics Analysis with Data from the Gene Expression Omnibus (GEO) Database.
Zheng L; Dou X; Ma X; Qu W; Tang X
Biomed Res Int; 2020; 2020():8341097. PubMed ID: 32724813
[TBL] [Abstract] [Full Text] [Related]
19. Up-regulation of hypoxia-inducible factor antisense as a novel approach to treat ovarian cancer.
Lu T; Tang J; Shrestha B; Heath BR; Hong L; Lei YL; Ljungman M; Neamati N
Theranostics; 2020; 10(15):6959-6976. PubMed ID: 32550915
[TBL] [Abstract] [Full Text] [Related]
20. Management of low-risk prostate cancer in patients with enlarged glands and lower urinary tract symptoms: robotic total prostatectomy, a novel technique.
Pathak RA; Hemal AK
World J Urol; 2020 Apr; 38(4):829-836. PubMed ID: 31538243
[TBL] [Abstract] [Full Text] [Related]
[Next]
